G. Gaskin

发表

Anti-neutrophil cytoplasmic antibodies and disease activity during long-term follow-up of 70 patients with systemic vasculitis.

C. Pusey, A. Rees, G. Gaskin, 1991, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Relationship between disease activity and anti-neutrophil cytoplasmic antibody concentration in long-term management of systemic vasculitis.

A. Dash, C. Pusey, A. Rees, 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

European therapeutic trials in ANCA‐associated systemic vasculitis: disease scoring, consensus regimens and proposed clinical trials EUROPEAN COMMUNITY STUDY GROUP ON CLINICAL TRIALS IN SYSTEMIC VASCULITIS ECSYSVASTRIAL (BMHl‐Cr93‐1078)

C. Kallenberg, C. Feighery, D. Abramowicz, 1995, Clinical and experimental immunology.

ANCA and predicting relapse in systemic vasculitis.

C. Pusey, D. Jayne, G. Gaskin, 1995, QJM : monthly journal of the Association of Physicians.

Relationship between granulocyte activation, pulmonary granulocyte kinetics and alveolar permeability in extrapulmonary inflammatory disease.

C. Pusey, A. Peters, J. Savill, 1996, Clinical science.

Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization.

P Lesavre, G Gaskin, J Hermans, 1998, Kidney international.

Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis.

D. Abramowicz, C. Pusey, C. Savage, 2007, Journal of the American Society of Nephrology : JASN.

Chances of renal recovery for dialysis-dependent ANCA-associated glomerulonephritis.

R. Wolterbeek, R. Waldherr, C. Pusey, 2007, Journal of the American Society of Nephrology : JASN.

Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: A prospective analysis of 100 patients with severe renal involvement.

R. Wolterbeek, R. Waldherr, F. Ferrario, 2006, Journal of the American Society of Nephrology : JASN.

Long-term renal injury in ANCA-associated vasculitis: an analysis of 31 patients with follow-up biopsies.

H. V. van Houwelingen, Emile de Heer, R. Waldherr, 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Plasmapheresis in antineutrophil cytoplasmic antibody-associated systemic vasculitis.

C. Pusey, G. Gaskin, C. Pusey, 2001, Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis.

Crescentic glomerulonephritis and systemic vasculitis

G. Gaskin, C. Pusey, 1999 .

The value of indirect immunofluorescence and solid phase techniques for ANCA detection. A report on the first phase of an international cooperative study on the standardization of ANCA assays. EEC/BCR Group for ANCA Assay Standardization.

A. Wiik, M. Daha, C. Pusey, 1993, Journal of immunological methods.

Interstitial lung disease and ANCA-associated vasculitis: a retrospective observational cohort study.

P. Ind, A. Salama, C. Pusey, 2011, Rheumatology.

Interstitial lung disease and ANCA-associated vasculitis: a retrospective observational cohort study RHEUMATOLOGY

P. Ind, A. Salama, C. Pusey, 2011 .

Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study.

C. Pusey, D. Jayne, M. Almond, 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Towards a more rapid diagnosis of rapidly progressive glomerulonephritis.

A. Rees, J. Savill, G. Gaskin, 1990, BMJ.

Renal Disease in the Churg-Strauss Syndrome

C. Pusey, G. Gaskin, E. Clutterbuck, 1991 .

Renal disease in the Churg-Strauss syndrome. Diagnosis, management and outcome.

C. Pusey, G. Gaskin, E. Clutterbuck, 1991, Contributions to nephrology.

HLA class II specificities in vasculitis with antibodies to neutrophil cytoplasmic antigens.

A. Rees, G. Gaskin, C. Pusey, 1992, Kidney international.

Autoantibodies developing to myeloperoxidase and proteinase 3 in systemic vasculitis stimulate neutrophil cytotoxicity toward cultured endothelial cells.

J. Pearson, C. Pusey, G. Gaskin, 1992, The American journal of pathology.

C-antineutrophil cytoplasmic antibody positivity in vasculitis patients is associated with the Z allele of alpha-1-antitrypsin, and P-antineutrophil cytoplasmic antibody positivity with the S allele.

C. Pusey, G. Gaskin, D. Whitehouse, 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Myeloperoxidase binds to vascular endothelial cells, is recognized by ANCA and can enhance complement dependent cytotoxicity.

C. Pusey, G. Gaskin, C. Savage, 1993, Advances in experimental medicine and biology.

Vascular damage in Wegener's granulomatosis and microscopic polyarteritis: presence of anti‐endothelial cell antibodies and their relation to anti‐neutrophil cytoplasm antibodies

J. Pearson, C. Pusey, C. Savage, 1991, Clinical and experimental immunology.

Classification, pathogenesis, and treatment of systemic vasculitis.

G. Gaskin, C. Pusey, M. Griffith, 1996, Renal failure.

Relationship between disease activity and ANCA level by ELISA in the long-term management of vasculitis.

A. Dash, A. Rees, G. Gaskin, 1993, Advances in experimental medicine and biology.

Significance of autoantibodies to purified proteinase 3 in systemic vasculitis.

A. Rees, G. Gaskin, J. Ryan, 1993, Advances in experimental medicine and biology.

Urinary monocyte chemoattractant protein-1 (MCP-1) is a marker of active renal vasculitis.

C. Kallenberg, T. Dougan, J. Levy, 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

A351 Serum FLC Levels Can Be Reduced Rapidly; Lower Levels Are Associated with Renal Recovery

Cohen, W. Gregory, M. Drayson, 2009 .

Adjunctive plasma exchange is superior to methylprednisolone in acute renal failure due to ANCA-associated glomerulonephritis.

R. Luqmani, D. Jayne, G. Gaskin, 2002 .

Anti-neutrophil cytoplasm antibodies can recognize vascular endothelial cell-bound anti-neutrophil cytoplasm antibody-associated autoantigens.

C. Pusey, G. Gaskin, C. Savage, 1993, Experimental nephrology.

Disease associations with anti-neutrophil cytoplasmic antibodies.

G. Gaskin, C. Pusey, 1993, Advances in experimental medicine and biology.

Rituximab is effective in the treatment of refractory Churg-Strauss syndrome and is associated with diminished T-cell interleukin-5 production.

A. Salama, R. Pepper, G. Gaskin, 2008, Rheumatology.

Outcome of renal replacement therapy in antineutrophil cytoplasmic antibody-associated systemic vasculitis.

C. Pusey, G. Gaskin, C. Pusey, 1998, Journal of the American Society of Nephrology : JASN.

A retrospective study of radiolabeled granulocyte kinetics in patients with systemic vasculitis.

C. Pusey, A. Peters, G. Gaskin, 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies.

V. Tesar, P. Bacon, C. Pusey, 2003, The New England journal of medicine.

Management of Rapidly Progressive Glomerulonephritis

G. Gaskin, 1997, Journal of the Royal College of Physicians of London.

ANCA-associated renal disease.

G. Gaskin, C. Pusey, 1993, The Quarterly journal of medicine.

Renal function and ear, nose, throat involvement in anti-neutrophil cytoplasmic antibody-associated vasculitis: prospective data from the European Vasculitis Society clinical trials.

R. Wolterbeek, R. Waldherr, C. Pusey, 2015, Rheumatology.

Long‐term follow‐up in 49 patients with microscopic polyarteritis

A. Rees, G. Gaskin, C. Pusey, 1990 .

Treatment of primary systemic vasculitis

A. Rees, G. Gaskin, C. Pusey, 1990, APMIS. Supplementum.

Immunosuppression for progressive membranous nephropathy: a UK randomised controlled trial

D. Adu, J. Feehally, P. Mathieson, 2013, The Lancet.

Development and standardization of solid phase assays for the detection of anti-neutrophil cytoplasmic antibodies (ANCA). A report on the second phase of an international cooperative study on the standardization of ANCA assays.

C. Kallenberg, A. Wiik, M. Daha, 1996, Journal of immunological methods.

ANCA-Associated Glomerulonephritis: Risk Factors for Renal Relapse

R. Waldherr, C. Pusey, F. Ferrario, 2016, PloS one.

Use of proteinase 3 purified by reverse phase HPLC to detect autoantibodies in systemic vasculitis.

C. Pusey, G. Gaskin, A. Coulthart, 1995, Journal of immunological methods.

Immunology of systemic vasculitis.

G. Gaskin, C. Pusey, 1992, Annales de medecine interne.

Goodpaststure-like syndrome associated with anti-myeloperoxidase antibodies following pencillamine treatment

C. Pusey, G. Gaskin, E. Thompson, 1995 .

Goodpasture-like syndrome associated with anti-myeloperoxidase antibodies following penicillamine treatment.

C. Pusey, G. Gaskin, E. Thompson, 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Cholesterol emboli syndrome

C. Pusey, G. Gaskin, A. Warrens, 2000, BMJ : British Medical Journal.

Plasma exchange is not excluded as a useful therapy in vasculitis-associated glomerulonephritis.

G. Gaskin, C. Pusey, 1997, Annales de medecine interne.

Renal transplantation following immunoadsorption in highly sensitized recipients.

R. Lechler, A. Rees, G. Gaskin, 1993, Transplantation.

What can we do about patients presenting with myeloma and severe renal failure? Observations from the UK MERIT plasma exchange trial

M. Drayson, J. Barratt, G. Cook, 2022, EJHaem.

Anti‐myeloperoxidase antibodies in vasculitis: Relationship to ANCA and clinical diagnosis

A. Rees, G. Gaskin, J. Ryan, 1990 .

Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: A prospective analysis of 100 patients with severe renal involvement.

R. Wolterbeek, R. Waldherr, F. Ferrario, 2006, Journal of the American Society of Nephrology : JASN.